Moreover, we could show that culprit site MCP-1 levels were significantly associated with infarct size in a multiple linear regression model complementing previous data on MCP-1 levels and patient survival after STEMI (de Lemos et al., 2007). This evidence concerns the gene CCL2 and infarction.